Apnimed, Inc. Logo (full size)
Apnimed, Inc. Logo icon/symbol
Apnimed, Inc. Logo (full size) on a dark background
Apnimed, Inc. Logo icon/symbol on a dark background
About Apnimed, Inc.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
August 1st, 2026
